Novel staphylococcal glycosyltransferases SdgA and SdgB mediate immunogenicity and protection of virulence-associated cell wall proteins.
Wouter L W Hazenbos,Kimberly K Kajihara,Richard Vandlen,J Hiroshi Morisaki,Sophie M Lehar,Mark J Kwakkenbos,Tim Beaumont,Arjen Q Bakker,Qui Phung,Lee R Swem,Satish Ramakrishnan,Janice Kim,Min Xu,Ishita M Shah,Binh An Diep,Tao Sai,Andrew Sebrell,Yana Khalfin,Angela Oh,Chris Koth,S Jack Lin,Byoung-Chul Lee,Magnus Strandh,Klaus Koefoed,Peter S Andersen,Hergen Spits,Eric J Brown,Man-Wah Tan,Sanjeev Mariathasan
DOI: https://doi.org/10.1371/journal.ppat.1003653
IF: 7.464
2013-01-01
PLoS Pathogens
Abstract:Infection of host tissues by Staphylococcus aureus and S. epidermidis requires an unusual family of staphylococcal adhesive proteins that contain long stretches of serine-aspartate dipeptide-repeats (SDR). The prototype member of this family is clumping factor A (ClfA), a key virulence factor that mediates adhesion to host tissues by binding to extracellular matrix proteins such as fibrinogen. However, the biological siginificance of the SDR-domain and its implication for pathogenesis remain poorly understood. Here, we identified two novel bacterial glycosyltransferases, SdgA and SdgB, which modify all SDR-proteins in these two bacterial species. Genetic and biochemical data demonstrated that these two glycosyltransferases directly bind and covalently link N-acetylglucosamine (GlcNAc) moieties to the SDR-domain in a step-wise manner, with SdgB appending the sugar residues proximal to the target Ser-Asp repeats, followed by additional modification by SdgA. GlcNAc-modification of SDR-proteins by SdgB creates an immunodominant epitope for highly opsonic human antibodies, which represent up to 1% of total human IgG. Deletion of these glycosyltransferases renders SDR-proteins vulnerable to proteolysis by human neutrophil-derived cathepsin G. Thus, SdgA and SdgB glycosylate staphylococcal SDR-proteins, which protects them against host proteolytic activity, and yet generates major eptopes for the human antistaphylococcal antibody response, which may represent an ongoing competition between host and pathogen.